Protocol No
CVC-JH-REACT-AF
Staff Member
Jason Rubenstein
Phase
III
Summary
This research is being done to assess whether it is safe and effective to stop oral anticoagulation medications (a blood-thinning medication) during prolonged periods of normal heart rhythm in participants with infrequent episodes of atrial fibrillation (AF).
Objective
REACT-AF Monitoring AFib
Study Sites
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
ClinicalTrials.gov